Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D02RQT
|
|||
| Former ID |
DNC014533
|
|||
| Drug Name |
Tenidap
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Rheumatoid arthritis [ICD-11: FA20] | Phase 3 | [1], [2] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C14H9ClN2O3S
|
|||
| Canonical SMILES |
C1=CSC(=C1)C(=O)C2=C(N(C3=C2C=C(C=C3)Cl)C(=O)N)O
|
|||
| InChI |
1S/C14H9ClN2O3S/c15-7-3-4-9-8(6-7)11(13(19)17(9)14(16)20)12(18)10-2-1-5-21-10/h1-6,19H,(H2,16,20)
|
|||
| InChIKey |
IZSFDUMVCVVWKW-UHFFFAOYSA-N
|
|||
| CAS Number |
CAS 120210-48-2
|
|||
| PubChem Compound ID | ||||
| PubChem Substance ID |
7980752, 14718345, 14874738, 26683989, 26686056, 29216033, 31919866, 47207730, 50064246, 53789318, 88531322, 104829165, 135028984, 135651243, 135698204, 137231438, 143388439, 160671983, 164150758, 164814894, 172914502, 179149455, 179294229, 198938260, 198993721, 204359548, 226413131, 227840142, 252156629, 252356965
|
|||
| ChEBI ID |
CHEBI:35847
|
|||
| SuperDrug ATC ID |
M01AX23
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Arachidonate 5-lipoxygenase (5-LOX) | Target Info | Modulator | [2] |
| BioCyc | Aspirin-triggered lipoxin biosynthesis | |||
| Resolvin D biosynthesis | ||||
| Leukotriene biosynthesis | ||||
| Lipoxin biosynthesis | ||||
| Aspirin triggered resolvin D biosynthesis | ||||
| Aspirin triggered resolvin E biosynthesis | ||||
| KEGG Pathway | Arachidonic acid metabolism | |||
| Metabolic pathways | ||||
| Serotonergic synapse | ||||
| Ovarian steroidogenesis | ||||
| Toxoplasmosis | ||||
| NetPath Pathway | IL4 Signaling Pathway | |||
| Pathwhiz Pathway | Arachidonic Acid Metabolism | |||
| WikiPathways | Vitamin D Receptor Pathway | |||
| Arachidonic acid metabolism | ||||
| Eicosanoid Synthesis | ||||
| Selenium Micronutrient Network | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2395). | |||
| REF 2 | The in vitro free radical scavenging activity of tenidap, a new dual cyclo-oxygenase and 5-1ipoxygenase inhibitor. Mediators Inflamm. 1992;1(2):141-3. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.